FDA notifications.  Rare complication with didanosine.
D016049:Didanosine / Q000009:adverse effects*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D018894:Reverse Transcriptase Inhibitors; D016049:Didanosine